Biohaven Ltd.
BHVN
$15.00
$0.281.90%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -9.46% | 27.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.24% | 23.37% | |||
| Operating Income | 4.24% | -23.37% | |||
| Income Before Tax | -5.11% | 10.29% | |||
| Income Tax Expenses | 43.75% | -22.51% | |||
| Earnings from Continuing Operations | -5.19% | 10.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.19% | 10.32% | |||
| EBIT | 4.24% | -23.37% | |||
| EBITDA | 4.23% | -24.15% | |||
| EPS Basic | -3.08% | 26.98% | |||
| Normalized Basic EPS | -2.46% | 2.08% | |||
| EPS Diluted | -3.08% | 26.98% | |||
| Normalized Diluted EPS | -2.46% | 2.08% | |||
| Average Basic Shares Outstanding | 2.05% | 22.82% | |||
| Average Diluted Shares Outstanding | 2.05% | 22.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||